Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udayan Chatterji

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Antimicrobial Agents and Chemotherapy|May 5, 2010
Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agentMichael D Bobardt, Udayan Chatterji, Lana Schaffer, et al.
Plos One|April 23, 2016
Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Plos One|June 11, 2019
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic micePhilippe Gallay, Daren Ure, Michael Bobardt, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexesSam Hopkins, Michael Bobardt, Udayan Chatterji, et al.
Nature Structural & Molecular Biology|December 14, 2004
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virusAymeric de Parseval, Udayan Chatterji, Garrett Morris, et al.
Plos One|February 18, 2014
HCV core residues critical for infectivity are also involved in core-NS5A complex formationKatarzyna Gawlik, James Baugh, Udayan Chatterji, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activitiesRichard Maskiewicz, Michael Bobardt, Udayan Chatterji, et al.
Plos One|August 12, 2015
The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe A Gallay, Michael D Bobardt, Udayan Chatterji, et al.
Gastroenterology|October 12, 2014
Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen productionSandra Phillips, Shilpa Chokshi, Udayan Chatterji, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Antimicrobial Agents and Chemotherapy|May 5, 2010
Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agentMichael D Bobardt, Udayan Chatterji, Lana Schaffer, et al.
Plos One|April 23, 2016
Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, et al.
The Journal of Biological Chemistry|October 10, 2006
Trim5alpha accelerates degradation of cytosolic capsid associated with productive HIV-1 entryUdayan Chatterji, Michael D Bobardt, Peter Gaskill, et al.
Plos One|June 11, 2019
The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic micePhilippe Gallay, Daren Ure, Michael Bobardt, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2012
The cyclophilin inhibitor SCY-635 disrupts hepatitis C virus NS5A-cyclophilin A complexesSam Hopkins, Michael Bobardt, Udayan Chatterji, et al.
Nature Structural & Molecular Biology|December 14, 2004
Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virusAymeric de Parseval, Udayan Chatterji, Garrett Morris, et al.
Plos One|February 18, 2014
HCV core residues critical for infectivity are also involved in core-NS5A complex formationKatarzyna Gawlik, James Baugh, Udayan Chatterji, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activitiesRichard Maskiewicz, Michael Bobardt, Udayan Chatterji, et al.
Plos One|August 12, 2015
The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of ActionPhilippe A Gallay, Michael D Bobardt, Udayan Chatterji, et al.
Gastroenterology|October 12, 2014
Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen productionSandra Phillips, Shilpa Chokshi, Udayan Chatterji, et al.
Pageof 5